The role of pretreatment FDG-PET in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 561-566

  Liu, Wen Shan ^a   Wu, Ming Fang ^a   Tseng, Hsien Chun ^a   Liu, Jung Tung ^a   Weng, Jui Hung ^a   Li, Yueh Chun ^a   Lee, Jong Kang ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

18F FDG PET; Nasopharyngeal carcinoma; Therapeutic outcome

Indexed keywords

18F-FDG-PET; CLINICAL OUTCOME; DISEASE-FREE SURVIVAL; FAILURE-FREE SURVIVAL; FDG-PET; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; INTENSITY-MODULATED RADIATION THERAPY; INTENSITY-MODULATED RADIOTHERAPY; KAPLAN-MEIER METHOD; MULTI VARIATE ANALYSIS; NASOPHARYNGEAL CARCINOMA; OVERALL SURVIVAL; PRE-TREATMENT; PROGNOSTIC SIGNIFICANCE; STANDARDIZED UPTAKE VALUES; THERAPEUTIC OUTCOME; UNIVARIATE;

CHEMOTHERAPY; DISEASE CONTROL; FAULT TOLERANT COMPUTER SYSTEMS; MULTIVARIANT ANALYSIS; NATURAL LANGUAGE PROCESSING SYSTEMS; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY;

PHYSICAL THERAPY;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PROGNOSIS; CANCER STAGING; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG TUMOR LEVEL; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCAL FAILURE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOACTIVITY; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862908773     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.055     Document Type: Article

References (28)

1. W.I. Wei, and J.S.T. Sham Nasopharyngeal carcinoma Lancet 365 2005 2041 2054
2. M.T. Liu, C.Y. Hsieh, and T.H. Chang Prognostic factors affecting the outcome of nasopharyngeal carcinoma Jpn J Clin Oncol 33 2003 501 508
3. D.T. Chua, J.S. Sham, D.L. Kwong, and G.K. Au Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma Cancer 98 2003 74 80
4. A.W. Lee, S.C. Law, and W. Foo Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: Survival after local recurrence Int J Radiat Oncol Biol Phys 26 1993 773 782
5. C.A. Perez, V.R. Devineni, and V. Marcial-Vega Carcinoma of the nasopharynx: Factors affecting prognosis Int J Radiat Oncol Biol Phys 23 1992 271 280
6. T.P. Farias, F.L. Dias, and R.A. Lima Prognostic factors and outcome for nasopharyngeal carcinoma Arch Otolaryngol Head Neck Surg 129 2003 794 799
7. W.M. Sze, A.W. Lee, and T.K. Yau Primary tumor volume of nasopharyngeal carcinoma: Prognostic significance for local control Int J Radiat Oncol Biol Phys 59 2004 21 27
8. J.S. Sham, and D. Choy Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival Head Neck 13 1991 298 310
9. I.W. Tham, S. Lin, and J. Pan Intensity-modulated radiation therapy without concurrent chemotherapy for Stage IIb nasopharyngeal cancer Am J Clin Oncol 33 2010 294 299
10. N. Lee, J. Harris, and A.S. Garden Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group Phase II trial 0225 J Clin Oncol 27 2009 3684 3690
11. S.C. Chan, J.T. Chang, and H.M. Wang Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value Oral Oncol 45 2009 52 58
12. 18F-FDG PET/CT for monitoring the response of lymphoma to radioimmunotherapy J Nucl Med 50 2009 8 17
13. A.S. Allas, D.O. Slosman, and T.K. Ani Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose Int J Radiation Oncology Biol Phys 59 2004 1295 1300
14. 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx J Nucl Med 48 2007 752 757
15. 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for stage T4 nasopharyngeal carcinoma Int J Radiation Oncology Biol Phys 65 2006 1307 1314
16. S.W. Lee, S.Y. Nam, and K.C. Im Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy- d-glucose positron emission tomography for nasopharyngeal carcinomas Radiother Oncol 87 2008 211 216
17. L.H. Sobin, and C.H. Wittekind TNM classification of malignant tumours 5th ed 1997 Springler-Verlag Berlin
18. W.S. Liu, H.C. Kuo, and J.C. Lin Assessment of salivary function change in nasopharyngeal carcinoma treated by parotid-sparing radiotherapy Cancer J 12 2006 494 500
19. L. Han, S.J. Lin, and J.J. Pan Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy Chin J Cancer 29 2010 145 150
20. C. Reisser, K. Eichhorn, and C. Herold-Mende Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck Int J Cancer 80 1999 194 198
21. M. Kunkel, T.E. Reichert, and P. Benz Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma Cancer 97 2003 1015 1024
22. H. Minn, H. Joensuu, A. Ahonen, and P. Klein Fluorodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo: Comparison with DNA flow cytometry in head and neck tumors Cancer 61 1998 1776 1781
23. 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies J Nucl Med 47 2006 410 418
24. H. Minn, M. Lapela, and P.J. Klemi Prediction of survival with fluorine-18-fluoro- deoxyglucose and PET in head and neck cancer J Nucl Med 38 1997 1907 1911
25. Inokuchi H, Kodaira T, Tachibana H, et al. Clinical usefulness of [(18)F] fluoro-2-deoxy-d-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: Consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection. Int J Radiat Oncol Biol Phys. In press.
26. B.B. Ma, F.K. Mo, and A.T. Chan The prognostic significance of tumor vascular invasion and its association with plasma Epstein-Barr virus DNA, tumor volume and metabolic activity in locoregionally advanced nasopharyngeal carcinoma Oral Oncol 44 2008 1067 1072
27. P. Xie, J.B. Yue, and Z. Fu Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma Ann Oncol 21 2010 1078 1082
28. A. Lee, c. Perez, and S. Law Nasopharynx Perez and Brady's principles and practice of radiation oncology 5th edition 2008 Lipincott Williams & Wilkins Philadelphia 820 857